Toronto, Ontario–(Newsfile Corp. – November 24, 2025) – Powermax Minerals Inc. (CSE: PMAX) (the “Company” or “Powermax”) announces, further to its news release dated October 15th, 2025, that it has amended the exercise period of the warrants (“Warrants“) which comprise the non flow-through units (“Units“) it is offering (“Private Placement“) at a price of $0.76 per Unit. […]
Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) has received a non-binding indication of interest from Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, to acquire all of the outstanding shares of Select Medical for cash consideration of $16.00 to $16.20 per share of our common stock (the
NEW YORK, NY / ACCESS Newswire / November 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bitdeer Technologies Group ("Bitdeer Technologies Group") (NASDAQ:BTDR) concerning possible violations of federal securities laws. Bitdeer issued a press release on November 10, 2025, reporting its unaudited financial results for the third quarter
NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=179016&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
(HKSE:1877.HK),(Shenzhen:688180.SS), SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the JS001sc-002-III-NSCLC study has met its primary endpoints. JS001sc-002-III-NSCLC is a multi-center, open-label, randomized Phase 3 clinical study comparing
Junshi Biosciences Announces Primary Endpoints Met in JS001sc's Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC GlobeNewswire November 25, 2025 SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced
New York, New York–(Newsfile Corp. – November 24, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Jayud Global Logistics Ltd. (NASDAQ: JYD) between April 21, 2023 and April 30, 2025, both dates inclusive (the “Class Period”). A class action lawsuit
NEW YORK, NY / ACCESS Newswire / November 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alvotech ("Alvotech") (NASDAQ:ALVO) concerning possible violations of federal securities laws. On November 2, 2025, Alvotech published a press release notifying investors that the Company received a Complete Response Letter (CRL) from the
NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Marex Group plc (NASDAQ:MRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marex-group-plc-lawsuit-submission-form?prid=179051&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / November 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Varonis Systems, Inc. ("Varonis Systems, Inc.") (NASDAQ:VRNS) concerning possible violations of federal securities laws. On October 28, 2025, Varonis reported third quarter fiscal 2025 revenue below estimates on the back of weaker